Related Experiment Videos
Topical erythromycin with zinc in acne. A double-blind controlled study
Journal of the American Academy of Dermatology
|November 1, 1980
Summary
Topical erythromycin with zinc formulations demonstrated significant acne reduction, proving as effective as oral tetracycline for inflammatory lesions and superior to placebo for non-inflammatory lesions.
Area of Science:
- Dermatology
- Pharmacology
Background:
- Acne vulgaris is a common skin condition with various treatment options.
- Topical and oral antibiotics, alongside zinc, are frequently used to manage acne.
- Evaluating novel topical formulations is crucial for improving treatment efficacy.
Purpose of the Study:
- To compare the efficacy of topical erythromycin/zinc formulations against oral tetracycline and placebo for acne treatment.
- To assess the impact of topical erythromycin liquid and gel with zinc on acne severity, papules, pustules, and comedones.
Main Methods:
- A double-blind, controlled study involving 141 patients completing the trial.
- Comparison of 4% topical erythromycin liquid/gel with zinc against oral tetracycline and placebo.
- Standardized acne measurements (severity, papules, pustules, comedones) recorded over 10 weeks.
Main Results:
- Both topical erythromycin/zinc formulations were significantly more effective than placebo for reducing acne severity and papule counts.
- Topical treatments showed comparable efficacy to oral tetracycline in reducing inflammatory acne lesions.
- The erythromycin/zinc liquid formulation demonstrated statistically significant reduction in comedo grades by week 8.
Conclusions:
- Topical erythromycin with zinc presents a viable alternative to oral antibiotics for acne management.
- These formulations offer significant benefits in reducing both inflammatory and non-inflammatory acne lesions.
- Further research may explore long-term efficacy and patient adherence to topical treatments.